Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Acta Vet Scand
2016 Oct 20;58Suppl 1:63. doi: 10.1186/s13028-016-0245-0.
Show Gene links
Show Anatomy links
An individual approach to feline diabetes care: a case report and literature review.
Lewitt MS
,
Strage E
,
Church D
.
???displayArticle.abstract???
BACKGROUND: Achieving insulin independence is emerging as a realistic therapeutic goal in the management of feline diabetes mellitus.
CASE PRESENTATION: The management of an 11-year-old spayed female Burmese cat presenting with diabetes mellitus after corticosteroid administration is described. Remission was achieved after the frequency of insulin administration was increased to four times a day, and supported by intensive home blood glucose monitoring and a high protein, low carbohydrate diet.
CONCLUSION: Owners are important collaborators in feline diabetes care and, with intensive home monitoring, more frequent insulin treatment may lead to remission without hypoglycemia. More frequent insulin injections than recommended in the literature may be necessary to achieve glycemic control and used as an alternative to a longer-acting insulin.
Fig. 1. Total daily insulin doses (a) and all blood glucose values (b) from commencement of treatment until 1 week after cessation of insulin. The shaded area represents the normal blood glucose range. The broken arrow represents the time that caloric intake was restricted to a maximum of 75 g wet and 25 g dry food (Purina DM) and increased physical activity by encouraging play several times a day. The solid arrow indicates the time when insulin was ceased
Fig. 2. Daily blood glucose profiles on porcine lente insulin 12-hourly (a) and glargine 12-hourly (b), 8-hourly (c) and 6-hourly (d, e). Times of insulin administration are indicated by the arrows. The day from the start of insulin treatment and total daily units (U) of insulin are indicated to the right of each profile
Fig. 3. All blood glucose values from day 53 to day 79 of treatment. The shaded area represents the normal blood glucose range. The total daily glargine dose, that was divided and delivered 6-hourly, is shown
Appleton,
Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain.
2001, Pubmed
Appleton,
Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain.
2001,
Pubmed
Backus,
Gonadectomy and high dietary fat but not high dietary carbohydrate induce gains in body weight and fat of domestic cats.
2007,
Pubmed
Bennett,
Comparison of a low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus.
2006,
Pubmed
Coradini,
Effects of two commercially available feline diets on glucose and insulin concentrations, insulin sensitivity and energetic efficiency of weight gain.
2011,
Pubmed
Crenshaw,
Pretreatment clinical and laboratory evaluation of cats with diabetes mellitus: 104 cases (1992-1994).
1996,
Pubmed
Frank,
Use of a high-protein diet in the management of feline diabetes mellitus.
2001,
Pubmed
Gilor,
Pharmacodynamics of insulin detemir and insulin glargine assessed by an isoglycemic clamp method in healthy cats.
2010,
Pubmed
Gostelow,
Systematic review of feline diabetic remission: separating fact from opinion.
2014,
Pubmed
Kluger,
Triglyceride response following an oral fat tolerance test in Burmese cats, other pedigree cats and domestic crossbred cats.
2009,
Pubmed
Lederer,
Frequency of feline diabetes mellitus and breed predisposition in domestic cats in Australia.
2009,
Pubmed
Lee,
Potential predictive biomarkers of obesity in Burmese cats.
2013,
Pubmed
Marshall,
Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
2009,
Pubmed
Marshall,
Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats.
2008,
Pubmed
McCann,
Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire-based putative risk factor analysis.
2007,
Pubmed
Michiels,
Treatment of 46 cats with porcine lente insulin--a prospective, multicentre study.
2008,
Pubmed
Nack,
In cats with newly diagnosed diabetes mellitus, use of a near-euglycemic management paradigm improves remission rate over a traditional paradigm.
2014,
Pubmed
Niessen,
Evaluation of a quality-of-life tool for cats with diabetes mellitus.
2010,
Pubmed
O'Leary,
Investigation of diabetes mellitus in Burmese cats as an inherited trait: a preliminary study.
2013,
Pubmed
Panciera,
Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986).
1990,
Pubmed
Prahl,
Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals.
2007,
Pubmed
Rand,
Over representation of Burmese cats with diabetes mellitus.
1997,
Pubmed
Roomp,
Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.
2012,
Pubmed
Roomp,
Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine.
2009,
Pubmed
Roomp,
Management of diabetic cats with long-acting insulin.
2013,
Pubmed
Sieber-Ruckstuhl,
Remission of diabetes mellitus in cats with diabetic ketoacidosis.
2008,
Pubmed
Slingerland,
Indoor confinement and physical inactivity rather than the proportion of dry food are risk factors in the development of feline type 2 diabetes mellitus.
2009,
Pubmed
Tan,
Feline diabetes--personal experience.
2003,
Pubmed
Öhlund,
Incidence of Diabetes Mellitus in Insured Swedish Cats in Relation to Age, Breed and Sex.
2015,
Pubmed